A COVID treatment combination is Paxlovid: nirmatrelvir and ritonavir. The purpose of ritonavir in this combination is to reduce breakdown of nirmatrelvir. ○ True ○ False

Name several ways drug resistance can be prevented by medicalpersonnel and patients

Implementation (Take actions)How should the intervention or combination of interventions be performed,  requested, communicated, taught, etc.? What are the priority interventions? (Mark with asterisk) Hello, Can you please help me with this question about next case; The patient is a 35 year -old female with AIDS brought to the emergency room with a fever of 39oC and a three month history of copious diarrhea. On physical exam the patient is a well-developed, thin female in moderate distress. Vital signs-(supine) blood pressure 100/60, pulse 100 and (standing) blood pressure 80/40, pulse 125, respirations 18 and she was afebrile. HEENT exam was normal. Cardiac exam demonstrated an S1 and S2 without S3, S4 or murmur. Lungs were clear to auscultation and percussion. The abdomen was supple and minimally tender to palpation. Bowel sounds were hyperactive. Stool was guiac negative. Extremities were without cyanosis, clubbing or edema. Neurological exam was intact. Laboratory Data…

During clinical trial, which phase only focus on safety but not effectiveness of the tested drug? Phase 0 Phase 1 Phase 2 Phase 3 O Phase 4